Iterum Therapeutics plc - ROE
ITRM
Price:
$0.03
Market Cap:
$1.87M
Iterum Therapeutics plc is a clinical-stage biopharmaceutical firm dedicated to the development and commercialization of anti-infective treatments. The company operates across Ireland, Bermuda, and the United States. Its primary therapeutic candidate is sulopenem, an innovative antimicrobial compound available in both oral and intravenous formulations. Sulopenem is currently undergoing advanced (Phase III) clinical evaluation for its potential in addressing uncomplicated and complicated urinary tract infections, as well as complicated intra-abdominal infections. Established in 2015, Iterum Therapeutics maintains its corporate headquarters in Dublin, Ireland.
Industry
Biotechnology
IPO Date
2018-05-25
Stock Exchange
NASDAQ
Ticker
ITRM
PE Ratio
[-0.04]
ROE
[602.38%]
Current Ratio
[2.13]
Dividend Yield
[0%]
Enterprise Value
[24.60M]
Dividend History
The ROE as of June 2026 (TTM) for Iterum Therapeutics plc (ITRM) is 602.38%
According to Iterum Therapeutics plc’s latest financial reports and current stock price. The company's current ROE is 602.38%. This represents a change of 275.38% compared to the average of 160.47% of the last 4 quarters.
Iterum Therapeutics plc (ITRM) Historical ROE (quarterly & annually)
How has ITRM ROE performed in the past?
The mean historical ROE of Iterum Therapeutics plc over the last ten years is 124.43%. The current 602.38% ROE has changed 384.13% with respect to the historical average. Over the past ten years (40 quarters), ITRM's ROE was at its highest in in the September 2019 quarter at 1.01%. The ROE was at its lowest in in the March 2021 quarter at -313.87%.
Average
124.43%
Median
-59.40%
Minimum
-182.27%
Maximum
607.06%
Iterum Therapeutics plc (ITRM) ROE by Quarter and Year
Discovering the peaks and valleys of Iterum Therapeutics plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 44.50%
Maximum Annual ROE = 607.06%
Minimum Annual Increase = -477.61%
Minimum Annual ROE = -182.27%
| Year | ROE | Change |
|---|---|---|
| 2024 | 607.06% | 1.30% |
| 2023 | 599.27% | -477.61% |
| 2022 | -158.70% | -12.93% |
| 2021 | -182.27% | -277.20% |
| 2020 | 102.86% | -73.83% |
| 2019 | 393.06% | -465.34% |
| 2018 | -107.59% | 44.50% |
| 2017 | -74.46% | 25.36% |
Iterum Therapeutics plc (ITRM) Average ROE
How has ITRM ROE performed in the past?
The current ROE of Iterum Therapeutics plc (ITRM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
349.21%
5-year avg
193.64%
10-year avg
124.43%
Iterum Therapeutics plc (ITRM) ROE vs. Peers
How is ITRM’s ROE compared to its peers?
Iterum Therapeutics plc’s ROE is greater than Intensity Therapeutics, Inc. (-136.82%), greater than iBio, Inc. (-53.86%), greater than Rallybio Corporation (-14.39%), less than Pluri Inc. (203.55%), greater than AN2 Therapeutics, Inc. (-52.35%), greater than Boundless Bio, Inc. (-53.60%), greater than Sonnet BioTherapeutics Holdings, Inc. (-518.10%), greater than TAO Synergies Inc. (-120.29%), less than Q32 Bio Inc. (230.68%), greater than Klotho Neurosciences, Inc. (-137.57%),
| Company | ROE | Market cap |
|---|---|---|
| -136.82% | $7.39M | |
| -53.86% | $26.68M | |
| -14.39% | $92.63M | |
| 203.55% | $18.16M | |
| -52.35% | $137.01M | |
| -53.60% | $32.12M | |
| -518.10% | $8.43M | |
| -120.29% | $12.06M | |
| 230.68% | $152.04M | |
| -137.57% | $20.08M |
Build a custom stock screener for Iterum Therapeutics plc (ITRM) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Iterum Therapeutics plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Iterum Therapeutics plc (ITRM) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Iterum Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Iterum Therapeutics plc's ROE?
How is the ROE calculated for Iterum Therapeutics plc (ITRM)?
What is the highest ROE for Iterum Therapeutics plc (ITRM)?
What is the 3-year average ROE for Iterum Therapeutics plc (ITRM)?
What is the 5-year average ROE for Iterum Therapeutics plc (ITRM)?
How does the current ROE for Iterum Therapeutics plc (ITRM) compare to its historical average?